{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:02:58Z","timestamp":1773284578775,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,30]],"date-time":"2014-06-30T00:00:00Z","timestamp":1404086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101118","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T16:34:45Z","timestamp":1404232485000},"page":"e101118","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["In Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis"],"prefix":"10.1371","volume":"9","author":[{"given":"Hee-Chang","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Ji","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil Youl","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Haeng","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook-In","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyon E","family":"Choy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/529148","article-title":"Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997\u20132006","volume":"46","author":"AM Dechet","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7326\/0003-4819-109-4-318","article-title":"Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981\u20131987","volume":"109","author":"KC Klontz","year":"1988","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/648612","article-title":"RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus","volume":"201","author":"KJ Chung","year":"2010","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1073\/pnas.1014339108","article-title":"Vibrio vulnificus rtxA1 gene recombination generates toxin variants with altered potency during intestinal infection","volume":"108","author":"JS Kwak","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/infdis\/jir070","article-title":"RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis","volume":"203","author":"HR Lo","year":"2011","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/IAI.68.9.5096-5106.2000","article-title":"Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease","volume":"68","author":"KC Jeong","year":"2000","journal-title":"Infect Immun"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kim YR, Lee SE, Kang IC, Nam KI, Choy HE, <etal>et al<\/etal>.. (2013) A Bacterial RTX Toxin Causes Programmed Necrotic Cell Death Through Calcium-Mediated Mitochondrial Dysfunction. J Infect Dis.","DOI":"10.1093\/infdis\/jis746"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e55219","DOI":"10.1371\/journal.pone.0055219","article-title":"Distribution of virulence markers among Vibrio vulnificus isolates of clinical and environmental origin and regional characteristics in Japan","volume":"8","author":"N Yokochi","year":"2013","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e37553","DOI":"10.1371\/journal.pone.0037553","article-title":"Pyrosequencing-based comparative genome analysis of Vibrio vulnificus environmental isolates","volume":"7","author":"SS Morrison","year":"2012","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e26018","DOI":"10.1371\/journal.pone.0026018","article-title":"Relationship between localization on cellular membranes and cytotoxicity of Vibrio vulnificus hemolysin","volume":"6","author":"H Sugiyama","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/CCM.0b013e3181eeda2c","article-title":"Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study","volume":"38","author":"SC Chen","year":"2010","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/AAC.41.10.2214","article-title":"In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus","volume":"41","author":"YC Chuang","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1128\/AAC.46.11.3580-3584.2002","article-title":"In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus","volume":"46","author":"HJ Tang","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/AAC.42.6.1319","article-title":"Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection","volume":"42","author":"YC Chuang","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/archinte.166.19.2117","article-title":"Prognostic factors and antibiotics in Vibrio vulnificus septicemia","volume":"166","author":"JW Liu","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jac\/dkr476","article-title":"Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period","volume":"67","author":"SC Chen","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jinf.2008.08.003","article-title":"Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction","volume":"57","author":"DM Kim","year":"2008","journal-title":"J Infect"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1086\/509822","article-title":"Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy","volume":"195","author":"CM Kim","year":"2007","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.32.4.438","article-title":"Routes of quinolone permeation in Escherichia coli","volume":"32","author":"JS Chapman","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","first-page":"3696","article-title":"In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B. Antimicrob Agents Chemother","volume":"54","author":"GP Neupane","year":"2010"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijantimicag.2010.03.022","article-title":"In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi","volume":"36","author":"DM Kim","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/AAC.49.8.3489-3491.2005","article-title":"In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus","volume":"49","author":"DM Kim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","unstructured":"Korea Food and Drug Administration (2011) Guidelines for animal experiments and IACUC standard opreation. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mfds.go.kr\/labanimal\/index.do?mid=56&seq=11795&cmd=v\" xlink:type=\"simple\">http:\/\/www.mfds.go.kr\/labanimal\/index.do?mid=56&amp;seq=11795&amp;cmd=v<\/ext-link>. Accessed 7 June 2014."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/msb.2010.115","article-title":"Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery","volume":"7","author":"HU Kim","year":"2011","journal-title":"Mol Syst Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1462-5822.2007.01088.x","article-title":"Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells","volume":"10","author":"YR Kim","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref26","unstructured":"Clinical and Laboratory Standards Institute (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-eighth edition. Wayne: Clinical and Laboratory Standards Institute. M07\u2013A8."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/IAI.01499-06","article-title":"The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor","volume":"75","author":"SE Lee","year":"2007","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1128\/IAI.71.10.5461-5471.2003","article-title":"Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients","volume":"71","author":"YR Kim","year":"2003","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2010.05.037","article-title":"Resveratrol modulates RTX toxin-induced cytotoxicity through interference in adhesion and toxin production","volume":"642","author":"JR Kim","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1046\/j.1365-2958.2003.03536.x","article-title":"Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system","volume":"48","author":"SY Kim","year":"2003","journal-title":"Mol Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jac\/38.5.771","article-title":"The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens","volume":"38","author":"M Otsuki","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1179\/joc.2005.17.4.355","article-title":"In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa","volume":"17","author":"L Piccoli","year":"2005","journal-title":"J Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijantimicag.2008.10.027","article-title":"In vitro combination of cefotaxime and ciprofloxacin against non-typhoid salmonellae","volume":"33","author":"CM Chang","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s10096-012-1592-z","article-title":"Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model","volume":"31","author":"GP Neupane","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkf192","article-title":"Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid","volume":"50","author":"CG Gemmell","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.01201-06","article-title":"Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin","volume":"51","author":"O Dumitrescu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/AAC.42.11.2817","article-title":"Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates","volume":"42","author":"K Ohlsen","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/AAC.00926-12","article-title":"Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits","volume":"56","author":"A Saleh-Mghir","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2004.09.020","article-title":"Production of Vibrio vulnificus hemolysin in vivo and its pathogenic significance","volume":"324","author":"SE Lee","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1574-695X.2011.00855.x","article-title":"Protective mechanism of curcumin against Vibrio vulnificus infection","volume":"63","author":"HS Na","year":"2011","journal-title":"FEMS Immunol Med Microbiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:15:55Z","timestamp":1589030155000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101118"}},"subtitle":[],"editor":[{"given":"Lars","family":"Kaderali","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,30]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101118","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,30]]}}}